@article{ff061fbcb1fb4e9190546796d070fb89,
title = "Activation of the p75 Neurotrophin Receptor through Conformational Rearrangement of Disulphide-Linked Receptor Dimers",
abstract = "Ligand-mediated dimerization has emerged as a universal mechanism of growth factor receptor activation. Neurotrophins interact with dimers of the p75 neurotrophin receptor (p75NTR), but the mechanism of receptor activation has remained elusive. Here, we show that p75NTR forms disulphide-linked dimers independently of neurotrophin binding through the highly conserved Cys257 in its transmembrane domain. Mutation of Cys257 abolished neurotrophin-dependent receptor activity but did not affect downstream signaling by the p75NTR/NgR/Lingo-1 complex in response to MAG, indicating the existence of distinct, ligand-specific activation mechanisms for p75NTR. FRET experiments revealed a close association of p75NTR intracellular domains that was transiently disrupted by conformational changes induced upon NGF binding. Although mutation of Cys257 did not alter the oligomeric state of p75NTR, the mutant receptor was no longer able to propagate conformational changes to the cytoplasmic domain upon ligand binding. We propose that neurotrophins activate p75NTR by a mechanism involving rearrangement of disulphide-linked receptor subunits.",
keywords = "MOLNEURO, PROTEINS, SIGNALING",
author = "Mar{\c c}al Vilar and Ioannis Charalampopoulos and Kenchappa, {Rajappa S.} and Anastasia Simi and Esra Karaca and Alessandra Reversi and Soyoung Choi and Mark Bothwell and Ismael Mingarro and Friedman, {Wilma J.} and Giampietro Schiavo and Bastiaens, {Philippe I.H.} and Verveer, {Peter J.} and Carter, {Bruce D.} and Ib{\'a}{\~n}ez, {Carlos F.}",
note = "Funding Information: We thank Phil Barker for MC192 antibody; Moses Chao, Toshihide Yamashita, Anders Nykj{\ae}r, and Daniel Lee for RIP2, RhoGDI, sortilin, and Lingo-1 expression plasmids; and Neil McDonald for fruitful discussions. This work was supported by grants from the Swedish Foundation for Strategic Research (CEDB), the Swedish Research Council (33X-10908-10A and Linn{\'e} program), the Vth Framework Program of the European Union (QLG3-CT-1999-00573), and the National Institutes of Health (NIH 1 R01 MH071624-01A2). R.S.K. and B.D.C. were supported by the National Institutes of Health (R01 NS038220), A.R. and G.S. by Cancer Research UK, M.B. by the National Institutes of Health (NIH 5 R01NS47348), I.M. by the Spanish Ministry of Education (BFU2006-08542), and A.S by the Marie Curie RTN “ENDOCYTE” from the European Union FP6 Program.",
year = "2009",
month = apr,
day = "16",
doi = "10.1016/j.neuron.2009.02.020",
language = "English (US)",
volume = "62",
pages = "72--83",
journal = "Neuron",
issn = "0896-6273",
publisher = "Cell Press",
number = "1",
}